Anti-Cancer Drugs
About Anti-Cancer Drugs
Anti-Cancer Drugs is a peer-reviewed academic journal published by Lippincott Williams & Wilkins.
Editorial Perspective & Metric Analysis
Based on current metadata, Anti-Cancer Drugs maintains a standard position in the GB academic market. With an impact factor of 1.73, it remains a steady venue for researchers in its specific sub-fields.
| ISSN (Print) | 0959-4973 |
|---|---|
| ISSN (Online) | 1473-5741 |
| Publisher | Lippincott Williams & Wilkins |
| Country | United Kingdom |
| APC / Cost | Inquire with Publisher |
About Anti-Cancer Drugs
Anti-Cancer Drugs is a peer-reviewed academic journal published by Lippincott Williams & Wilkins.
Links
Frequently Asked Questions about Anti-Cancer Drugs
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Impact Factor
Historical Trend
Initial data points onlyImpact Factors by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 1.728 | CiteScore (Scopus) |
Works Published per Year (2014–2025)
Annual publication volume sourced from OpenAlex. Current year omitted (partial data).
Journal at a Glance
Source: OpenAlex — refreshed daily.
Top Research Topics
The areas where Anti-Cancer Drugs most frequently publishes, ranked by article volume.
-
529 worksCancer therapeutics and mechanismsBiochemistry, Genetics and Molecular Biology
-
523 worksCancer Treatment and PharmacologyMedicine
-
410 worksColorectal Cancer Treatments and StudiesMedicine
-
386 worksLung Cancer Treatments and MutationsMedicine
-
315 worksLung Cancer Research StudiesMedicine
-
238 worksDrug Transport and Resistance MechanismsMedicine
-
202 worksHER2/EGFR in Cancer ResearchMedicine
-
187 worksCancer-related Molecular PathwaysMedicine
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S158028025